CSI Market
Sign In | Register

Interpace Biosciences Inc (PDII) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access PDII Annual Balance Sheets →
From Interpace Biosciences Inc through Jun 30 2025, shifts in Jun 30 2026's assets and liabilities provide insight into the company's capital structure and financial stability.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent2.69
Cash & Short-term Investments2.00
Accounts receivable6.31
Inventories1.09
Other Current Assets0.70
Total loans net0.19
Total Current Assets10.97
Equipment/Property/Plant Net1.62
Other Assets, Noncurrent21.96
Operating Lease Right Of Use Asset1.11
Total Assets34.55
Liabilities
Accounts Payable, Current AC1.56
Employee-related Liabilities, Current AC0.95
Notes Payable, Current NO0.00
Other Liabilities, Current1.55
Taxes Payable0.24
Disposal Group, Including Discontinued Operation, Liabilities, Current LI0.66
Total Current Liabilities4.95
Total Long-term Debt0.00
Other liabilities, Noncurrent6.35
Operating Lease Liability Noncurrent0.64
Total Liabilities11.31
Stockholders' Equity
Common Stock Value0.64
Treasury Stock Value-2.08
Additional Paid In Capital Common Stock234.61
Retained Earnings / Accumulated Deficit-209.93
Other Equity0.00
Common Stockholder's Equity23.24
Total Stockholder's Equity23.24
Liabilities & Stockholder's Equity34.55
4 historic quarters locked

Sign in to unlock the full Interpace Biosciences Inc balance sheet history.

Sign In Create Free Account

About Interpace Biosciences Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20260630)
  • Filed with the SEC: August 10, 2026
  • Source: form10-q.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001493152-26-036895

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.